Cronos Group Inc. Company Profile
NASDAQ: CRONHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cronos Group at a glance
Cronos Group Inc. (NASDAQ: CRON) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector headquartered in Stayner, ON, Canada. Cronos Group is led by Mr. Michael Ryan Gorenstein J.D. and employs about 610 people. At a market capitalization of $1.21 billion, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001656472, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Cronos Group do?
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Business description based on the company's public filings.
Company information
- Legal name
- Cronos Group Inc.
- Ticker
- NASDAQ: CRON
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Michael Ryan Gorenstein J.D.
- Employees
- 610
- Headquarters
- 4491 Concession Road 12, Stayner, ON, Canada
- Phone
- 416 504 0004
- Website
- thecronosgroup.com
- Market cap
- $1.21B
- SEC CIK
- 0001656472
Companies similar to Cronos Group
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HROWHarrow Inc. | 30.62 | +0.89% | $1.15B | vs CRON |
| AMPHAmphastar Pharmaceuticals Inc. | 25.54 | -1.43% | $1.09B | vs CRON |
| PCRXPacira BioSciences Inc. | 25.20 | +1.78% | $1.00B | vs CRON |
| PAHCPhibro Animal Health Corporation Class A | 37.72 | +3.03% | $1.53B | vs CRON |
| ETONEton Pharmaceuticals Inc. | 54.88 | +0.20% | $1.57B | vs CRON |
| COLLCollegium Pharmaceutical Inc. | 21.93 | +0.23% | $713.94M | vs CRON |
| IRWDIronwood Pharmaceuticals Inc. Class A | 3.75 | +3.31% | $619.65M | vs CRON |
| AQSTAquestive Therapeutics Inc. | 4.62 | +0.22% | $579.86M | vs CRON |